[HTML][HTML] Ligand design strategies to increase stability of gadolinium-based magnetic resonance imaging contrast agents
Gadolinium (III) complexes have been widely utilised as magnetic resonance imaging (MRI)
contrast agents for decades. In recent years however, concerns have developed about their …
contrast agents for decades. In recent years however, concerns have developed about their …
Gadolinium-based contrast agent accumulation and toxicity: an update
J Ramalho, RC Semelka, M Ramalho… - American Journal …, 2016 - Am Soc Neuroradiology
In current practice, gadolinium-based contrast agents have been considered safe when
used at clinically recommended doses in patients without severe renal insufficiency. The …
used at clinically recommended doses in patients without severe renal insufficiency. The …
Safety of intrathecal administration of gadolinium-based contrast agents: a systematic review and meta-analysis
M Patel, A Atyani, JP Salameh, M McInnes… - Radiology, 2020 - pubs.rsna.org
Background The use of MR cisternography with intrathecal administration of gadolinium-
based contrast agents (GBCAs) is limited by a lack of understanding of the relationship …
based contrast agents (GBCAs) is limited by a lack of understanding of the relationship …
Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies
Purpose Gadolinium is a rare-earth lanthanide metal that is known to have a direct
neurotoxic effect. The scope of the present review is to summarize the current preclinical and …
neurotoxic effect. The scope of the present review is to summarize the current preclinical and …
Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis—an autopsy-based review
S Sanyal, P Marckmann, S Scherer… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. Nephrogenic systemic fibrosis (NSF) is a systemic disorder of patients with
severe renal insufficiency who have received gadolinium (Gd)-based magnetic resonance …
severe renal insufficiency who have received gadolinium (Gd)-based magnetic resonance …
The effect of perinatal gadolinium-based contrast agents on adult mice behavior
MA Khairinisa, Y Takatsuru, I Amano… - Investigative …, 2018 - journals.lww.com
Objectives The aim of this study was to examine the effects of perinatal exposure to
gadolinium (Gd)-based contrast agents (GBCAs) on the behavior of adulthood offspring …
gadolinium (Gd)-based contrast agents (GBCAs) on the behavior of adulthood offspring …
Intrathecal gadolinium-enhanced MR cisternography: a comprehensive review
CE-MRC has been in use for the past 15 years and was reported to be a useful method in
the evaluation of CSF disorders and hydrocephalus. The use of CE-MRC in conjunction with …
the evaluation of CSF disorders and hydrocephalus. The use of CE-MRC in conjunction with …
[HTML][HTML] Diagnosis and treatment of cerebrospinal fluid rhinorrhea following accidental traumatic anterior skull base fractures
M Ziu, JG Savage, DF Jimenez - Neurosurgical focus, 2012 - thejns.org
Cerebrospinal fluid rhinorrhea is a serious and potentially fatal condition because of an
increased risk of meningitis and brain abscess. Approximately 80% of all cases occur in …
increased risk of meningitis and brain abscess. Approximately 80% of all cases occur in …
Fatal gadolinium-induced encephalopathy following accidental intrathecal administration: a case report and a comprehensive evidence-based review
DA Provenzano, Z Pellis, L DeRiggi - Regional Anesthesia & Pain …, 2019 - rapm.bmj.com
Gadolinium-based contrast agents (GBCAs) have been suggested as off-label alternatives
to iodine-based contrast agents for fluoroscopic imaging during interventional pain …
to iodine-based contrast agents for fluoroscopic imaging during interventional pain …
Gadolinium released from MR contrast agents is deposited in brain tumors: in situ demonstration using scanning electron microscopy with energy dispersive X-ray …
D Xia, RL Davis, JA Crawford, JL Abraham - Acta Radiologica, 2010 - Taylor & Francis
Background: Gadolinium (Gd)-containing MRI contrast agents (GdCA) are widely used in
studies of brain tumors, and a number of reports suggest that under certain conditions, such …
studies of brain tumors, and a number of reports suggest that under certain conditions, such …